|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Type 2 diabetes mellitus with neurological complications
ICD-10 (CM) Code and Descriptor
|
E11.43 |
Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy
|
E1143 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 21.39%
|
15.82%
|
14.50%
|
11.46%
|
8.85%
|
6.75%
|
5.13%
|
3.79%
|
2.87%
|
2.09%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E11.43*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,131
|
6,194
|
|
80053
|
COMPREHEN METABOLIC PANEL |
5,996
|
6,000
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
5,452
|
5,469
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
4,951
|
4,951
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,796
|
3,809
|
|
97530
|
THERAPEUTIC ACTIVITIES |
2,945
|
4,756
|
|
97110
|
THERAPEUTIC EXERCISES |
2,810
|
4,281
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
2,780
|
13,917
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
2,542
|
2,544
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
2,536
|
5,193
|
|
83690
|
ASSAY OF LIPASE |
2,444
|
2,463
|
|
80061
|
LIPID PANEL |
2,406
|
2,406
|
|
80048
|
METABOLIC PANEL TOTAL CA |
2,359
|
2,384
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,356
|
13,192
|
|
96374
|
THER/PROPH/DIAG INJ IV PUSH |
2,271
|
2,277
|
|
82962
|
GLUCOSE BLOOD TEST |
2,207
|
3,892
|
|
G0467
|
FQHC VISIT, ESTAB PT |
1,999
|
1,999
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
1,860
|
1,863
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
1,743
|
1,804
|
|
83735
|
ASSAY OF MAGNESIUM |
1,741
|
1,763
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E11.43 related to the following DRG Codes:
008
010
019
073-074
|
